Pharmacist services provided in general practice clinics: A systematic review and meta-analysis

Research in Social and Administrative Pharmacy

Volumn 10, Issue 4, 2014, Pages 608-622

  Tan, Edwin C K ^a   Stewart, Kay ^a   Elliott, Rohan A ^a,b   George, Johnson ^a  

^a MONASH UNIVERSITY   (Australia)

^b AUSTIN HEALTH   (Australia)

Author keywords

General practice; Meta analysis; Pharmacists; Primary health care; Systematic review

Indexed keywords

GENERAL PRACTICE; HUMAN; META ANALYSIS; PHARMACIST; PHARMACY; PROCEDURES; PROFESSIONAL STANDARD; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARDS;

GENERAL PRACTICE; HUMANS; PHARMACEUTICAL SERVICES; PHARMACISTS; PROFESSIONAL ROLE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84904105766     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2013.08.006     Document Type: Review

References (70)

1. What is General Practice? 2012, Royal Australian College of General Practitioners, Available from:, Accessed 27.05.13. http://www.racgp.org.au/whatisgeneralpractice.
2. Nkansah N., Mostovetsky O., Yu C., et al. Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database Syst Rev 2010, CD000336.
3. Bell J., Kalisch L., Ramsay E., et al. Prescriber feedback to improve quality use of medicines among older people: the veterans' MATES program. J Pharm Pract Res 2001, 41:316-319.
4. Pojskic N., MacKeigan L., Boon H., Ellison P., Breslin C. Ontario family physician readiness to collaborate with community pharmacists on drug therapy management. Res Social Adm Pharm 2011, 7:39-50.
5. Dobson R.T., Henry C.J., Taylor J.G., et al. Interprofessional health care teams: attitudes and environmental factors associated with participation by community pharmacists. J Interprof Care 2006, 20:119-132.
6. Edmunds J., Calnan M.W. The reprofessionalisation of community pharmacy? An exploration of attitudes to extended roles for community pharmacists amongst pharmacists and General Practitioners in the United Kingdom. Soc Sci Med 2001, 53:943-955.
7. Dolovich L. Ontario pharmacists practicing in family health teams and the patient-centered medical home. Ann Pharmacother 2012, 46:S33-S39.
8. Bradley F., Elvey R., Ashcroft D.M., et al. The challenge of integrating community pharmacists into the primary health care team: a case study of local pharmaceutical services (LPS) pilots and interprofessional collaboration. J Interprof Care 2008, 22:387-398.
9. Farrell B., Ward N., Dore N., Russell G., Geneau R., Evans S. Working in interprofessional primary health care teams: what do pharmacists do?. Res Social Adm Pharm 2013, 9:288-301.
10. Dolovich L., Pottie K., Kaczorowski J., et al. Integrating family medicine and pharmacy to advance primary care therapeutics. Clin Pharmacol Ther 2008, 83:913-917.
11. Fish A., Watson M., Bond C. Practice-based pharmaceutical services: a systematic review. Int J Pharm Pract 2002, 10:225-233.
12. Hanlon J.T., Lindblad C.I., Gray S.L. Can clinical pharmacy services have a positive impact on drug-related problems and health outcomes in community-based older adults?. Am J Geriatr Pharmacother 2004, 2:3-13.
13. Geurts M.M., Talsma J., Brouwers J.R., de Gier J.J. Medication review and reconciliation with cooperation between pharmacist and general practitioner and the benefit for the patient: a systematic review. Br J Clin Pharmacol 2012, 74:16-33.
14. Haynes R.B., Ackloo E., Sahota N., McDonald H.P., Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008, CD000011.
15. Chisholm-Burns M.A., Kim Lee J., Spivey C.A., et al. US pharmacists' effect as team members on patient care: systematic review and meta-analyses. Med Care 2010, 48:923-933.
16. Higgins J., Altman D., Sterne J. Chapter 8: assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration 2011, Available from:. http://www.cochrane-handbook.org, J.P.T. Higgins, S. Green (Eds.).
17. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
18. Borenstein M., Hedges L., Rothstein H. Meta-analysis: Fixed Effect vs. Random Effects 2007, Available from:, Accessed 30.08.13. http://www.meta-analysis.com/downloads/Meta-analysis%20fixed%20effect%20vs%20random%20effects.pdf.
19. Adler D.A., Bungay K.M., Wilson I.B., et al. The impact of a pharmacist intervention on 6-month outcomes in depressed primary care patients. Gen Hosp Psychiatry 2004, 26:199-209.
20. Borenstein J.E., Graber G., Saltiel E., et al. Physician-pharmacist comanagement of hypertension:a randomized, comparative trial. Pharmacotherapy 2003, 23:209-216.
21. Capoccia K.L., Boudreau D.M., Blough D.K., et al. Randomized trial of pharmacist interventions to improve depression care and outcomes in primary care. Am J Health Syst Pharm 2004, 61:364-372.
22. Carter B.L., Malone D.C., Billups S.J., et al. Interpreting the findings of the IMPROVE study. Am J Health Syst Pharm 2001, 58:1330-1337.
23. Carter B.L., Bergus G.R., Dawson J.D., et al. A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control. JClin Hypertens 2008, 10:260-271.
24. Choe H.M., Mitrovich S., Dubay D., Hayward R.A., Krein S.L., Vijan S. Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. Am J Manag Care 2005, 11:253-260.
25. Finley P.R., Rens H.R., Pont J.T., et al. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy 2003, 23:1175-1185.
26. Hanlon J.T., Weinberger M., Samsa G.P., et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 1996, 100:428-437.
27. Heisler M., Hofer T.P., Schmittdiel J.A., et al. Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high-performing health systems: the adherence and intensification of medications cluster randomized, controlled pragmatic trial. Circulation 2012, 125:2863-2872.
28. Hunt J.S., Siemienczuk J., Pape G., et al. A randomized controlled trial of team-based care: impact of physician-pharmacist collaboration on uncontrolled hypertension. J Gen Intern Med 2008, 23:1966-1972.
29. Jacobs M., Sherry P.S., Taylor L.M., Amato M., Tataronis G.R., Cushing G. Pharmacist Assisted Medication Program Enhancing the Regulation of Diabetes (PAMPERED) study. J Am Pharm Assoc 2012, 52:613-621.
30. Jameson J.P., VanNoord G.R. Pharmacotherapy consultation on polypharmacy patients in ambulatory care. Ann Pharmacother 2001, 35:835-840.
31. Jameson J.P., Baty P.J. Pharmacist collaborative management of poorly controlled diabetes mellitus: a randomized controlled trial. Am J Manag Care 2010, 16:250-255.
32. Kirwin J.L., Cunningham R.J., Sequist T.D. Pharmacist recommendations to improve the quality of diabetes care: a randomized controlled trial. J Manag Care Pharm 2010, 16:104-113.
33. Okamoto M.P., Nakahiro R.K. Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic. Pharmacotherapy 2001, 21:1337-1344.
34. Rothman R.L., Malone R., Bryant B., et al. A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes. Am J Med 2005, 118:276-284.
35. Scott D.M., Boyd S.T., Stephan M., Augustine S.C., Reardon T.P. Outcomes of pharmacist-managed diabetes care services in a community health center. Am J Health Syst Pharm 2006, 63:2116-2122.
36. Gourley D.R., Gourley G.A., Solomon D.K., et al. Development, implementation, and evaluation of a multicenter pharmaceutical care outcomes study. J Am Pharm Assoc 1998, 38:567-573.
37. Avery A.J., Rodgers S., Cantrill J.A., et al. A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis. Lancet 2012, 379:1310-1319.
38. Bond C.M., Fish A., Porteous T.H., Reid J.P., Scott A., Antonazzo E. A randomised controlled trial of the effects of note-based medication review by community pharmacists on prescribing of cardiovascular drugs in general practice. Int J Pharm Pract 2007, 15:39-46.
39. Granås A., Bates I. The effect of pharmaceutical review of repeat prescriptions in general practice. Int J Pharm Pract 1999, 7:264-275.
40. Hay E.M., Foster N.E., Thomas E., et al. Effectiveness of community physiotherapy and enhanced pharmacy review for knee pain in people aged over 55 presenting to primary care: pragmatic randomised trial. BMJ 2006, 333:995.
41. Jamieson L., Scally A., Chrystyn H. A randomised comparison of practice pharmacist-managed hypertension providing level 3 medication review versus usual care in general practice. J Appl Ther Res 2010, 7:77-86.
42. Lowrie R., Mair F.S., Greenlaw N., et al. Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction. Eur Heart J 2012, 33:314-324.
43. Zermansky A.G., Petty D.R., Raynor D.K., Freemantle N., Vail A., Lowe C.J. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ 2001, 6:1340-1343.
44. Deschamps M.A., Taylor J.G., Neubauer S.L., Whiting S., Green K. Impact of pharmacist consultation versus a decision aid on decision making regarding hormone replacement therapy. Int J Pharm Pract 2004, 12:21-28.
45. Evans C.D., Eurich D.T., Taylor J.G., Blackburn D.F. The Collaborative Cardiovascular Risk Reduction in Primary Care (CCARP) study. Pharmacotherapy 2010, 30:766-775.
46. Grymonpre R.E., Williamson D.A., Montgomery P.R. Impact of a pharmaceutical care model for non-institutionalised elderly: results of a randomised, controlled trial. Int J Pharm Pract 2001, 9:235-241.
47. Hogg W., Lemelin J., Dahrouge S., et al. Randomized controlled trial of anticipatory and preventive multidisciplinary team care: for complex patients in a community-based primary care setting. Can Fam Physician 2009, 55:e76-e85.
48. Sellors J., Kaczorowski J., Sellors C., et al. A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. Can Med Assoc J 2003, 169:17-22.
49. Simpson S.H., Majumdar S.R., Tsuyuki R.T., Lewanczuk R.Z., Spooner R., Johnson J.A. Effect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes: a randomized controlled trial. Diabetes Care 2011, 34:20-26.
50. Mourao A.O., Ferreira W.R., Martins M.A., et al. Pharmaceutical care program for type 2 diabetes patients in Brazil: a randomised controlled trial. Int J Clin Pharm 2013, 35:79-86.
51. Neto P.R., Marusic S., de Lyra Junior D.P., et al. Effect of a 36-month pharmaceutical care program on the coronary heart disease risk in elderly diabetic and hypertensive patients. J Pharm Pharm Sci 2011, 14:249-263.
52. Villa L.A., Von Chrismar A.M., Oyarzun C., Eujenin P., Fernandez M.E., Quezada M. Pharmaceutical care program for dyslipidemic patients at three primary health care centers: impacts and outcomes. Lat Am J Pharm 2009, 28:415-420.
53. Sookaneknun P., Richards R.M.E., Sanguansermsri J., Teerasut C. Pharmacist involvement in primary care improves hypertensive patient clinical outcomes. Ann Pharmacother 2004, 38:2023-2028.
54. Tobari H., Arimoto T., Shimojo N., et al. Physician-pharmacist cooperation PROGRAM for blood pressure control in patients with hypertension: a randomized-controlled trial. Am J Hypertens 2010, 23:1144-1152.
55. Tahaineh L., Albsoul-Younes A., Al-Ashqar E., Habeb A. The role of clinical pharmacist on lipid control in dyslipidemic patients in North of Jordan. Int J Clin Pharm 2011, 33:229-236.
56. Hammad E.A., Yasein N., Tahaineh L., Albsoul-Younes A.M. A randomized controlled trial to assess pharmacist- physician collaborative practice in the management of metabolic syndrome in a university medical clinic in Jordan. J Manag Care Pharm 2011, 17:295-303.
57. Solomon D.K., Portner T.S., Bass G.E., et al. Clinical and economic outcomes in the hypertension and COPD arms of a multicenter outcomes study. JAm Pharm Assoc (Wash) 1998, 38:574-585.
58. Carter B.L., Malone D.C., Valuck R.J., Barnette D.J., Sintek C.D., Billups S.J. The IMPROVE study: background and study design. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Am J Health Syst Pharm 1998, 55:62-67.
59. Gourley G.A., Portner T.S., Gourley D.R., et al. Humanistic outcomes in the hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc 1998, 38:586-597.
60. Zillich A., McDonough R.P., Carter B.L., Doucette W.R. Influential characteristics of physician/pharmacist collaborative relationships. Ann Pharmacother 2004, 38:764-770.
61. Glynn R.J., L'Italien G.J., Sesso H.D., Jackson E.A., Buring J.E. Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressure. Hypertension 2002, 39:105-110.
62. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352:837-853. UK Prospective Diabetes Study (UKPDS) Group.
63. Holland R., Desborough J., Goodyer L., Hall S., Wright D., Loke Y.K. Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. Br J Clin Pharmacol 2008, 65:303-316.
64. Collins C., Limone B.L., Scholle J.M., Coleman C.I. Effect of pharmacist intervention on glycemic control in diabetes. Diabetes Res Clin Pract 2011, 92:145-152.
65. Morgado M.P., Morgado S.R., Mendes L.C., Pereira L.J., Castelo-Branco M. Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: review and meta-analysis. Am J Health Syst Pharm 2011, 68:241-253.
66. Santschi V., Chiolero A., Burnand B., Colosimo A.L., Paradis G. Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials. Arch Intern Med 2011, 171:1441-1453.
67. Guillaume L., Cooper R., Avery A., et al. Supplementary prescribing by community and primary care pharmacists: an analysis of PACT data, 2004-2006. J Clin Pharm Ther 2008, 33:11-16.
68. George J., McCaig D.J., Bond C.M., et al. Supplementary prescribing: early experiences of pharmacists in Great Britain. Ann Pharmacother 2006, 40:1843-1850.
69. Tan ECK, Stewart K, Elliott RA, George J. Integration of pharmacists into general practice clinics in Australia: the views of general practitioners and pharmacists. Int J Pharm Pract. [Epub ahead of print]. http://dx.doi.org/10.1111/ijpp.12047.
70. Phelan M., Foster N.E., Thomas E., Hay E.M., Blenkinsopp A. Pharmacist-led medication review for knee pain in older adults: content, process and outcomes. Int J Pharm Pract 2008, 16:347-355.